These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers. Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219 [TBL] [Abstract][Full Text] [Related]
27. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Sato K; Nakajima K; Imamura H; Deguchi T; Horinouchi S; Yamazaki K; Yamada E; Kanaji Y; Takano K Endocr J; 2002 Dec; 49(6):625-33. PubMed ID: 12625412 [TBL] [Abstract][Full Text] [Related]
31. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Stolarski B; Pronicka E; Korniszewski L; Pollak A; Kostrzewa G; Rowińska E; Włodarski P; Skórka A; Gremida M; Krajewski P; Ploski R Clin Genet; 2006 Oct; 70(4):348-54. PubMed ID: 16965330 [TBL] [Abstract][Full Text] [Related]
32. Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease. Fierabracci A Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420045 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl. Kollios K; Tsolaki A; Antachopoulos C; Moix I; Morris MA; Papadopoulou M; Roilides E J Pediatr Endocrinol Metab; 2011; 24(7-8):599-601. PubMed ID: 21932610 [TBL] [Abstract][Full Text] [Related]
35. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily. Valenzise M; Fierabracci A; Cappa M; Porcelli P; Barcellona R; De Luca F; Barollo S; Garelli S; Betterle C Horm Res Paediatr; 2014; 82(2):127-32. PubMed ID: 25059117 [TBL] [Abstract][Full Text] [Related]
36. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Saugier-Veber P; Drouot N; Wolf LM; Kuhn JM; Frébourg T; Lefebvre H Eur J Endocrinol; 2001 Apr; 144(4):347-51. PubMed ID: 11275943 [TBL] [Abstract][Full Text] [Related]
37. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Perniola R; Falorni A; Clemente MG; Forini F; Accogli E; Lobreglio G Eur J Endocrinol; 2000 Oct; 143(4):497-503. PubMed ID: 11022196 [TBL] [Abstract][Full Text] [Related]
38. Serological proteome analysis reveals new specific biases in the IgM and IgG autoantibody repertoires in autoimmune polyendocrine syndrome type 1. Dubucquoi S; Proust-Lemoine E; Kemp EH; Ryndak A; Lefèvre-Dutoit V; Bellart M; Saugier-Véber P; Duban-Deweer S; Wémeau JL; Prin L; Lefranc D Autoimmunity; 2015; 48(8):532-41. PubMed ID: 26312540 [TBL] [Abstract][Full Text] [Related]